LPTX logo

Leap Therapeutics (LPTX)

Profile

Full Name

Leap Therapeutics, Inc.

Ticker Symbol

LPTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 25, 2017

Indexes

Not included

Website

http://www.leaptx.com

Employees

52

Key Details

Price

$0.37(-1.12%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.81(+54.52% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.37
LPTX price is $0.37

30-Day Relative Volume

0.76
LPTX 30-day relative volume is 0.76

Price Performance

Price Today change

-1.12%
LPTX price is down -1.12% today

Price YTD change

-87.14%
LPTX price is down -87.14% since January 1st

Price 1-year change

-87.59%
LPTX price is down -87.59% year-on-year

Price 3-year change

-97.67%
LPTX price is down -97.67% over the past 3 years

Price Range

Price All-time high

$102.50
LPTX price is currently -99.64% below its historical high of $102.50

Price 3-year low

$0.22
LPTX price is currently +66.58% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$15.26M
LPTX market capitalization is $15.26 million

Market cap 3-year change

-89.14%
LPTX market capitalization is down -89.14% over the past 3 years

Market cap All-time high

$352.23M
LPTX market capitalization is currently -95.67% below its historical high of $352.23 million

Market cap sector rank

24.92%
LPTX market capitalization is higher than 24.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+61.14%
LPTX shares outstanding is up +61.14% year-on-year

Shares Outstanding 3-Year Change

+367.15%
LPTX shares outstanding is up +367.15% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.18
LPTX beta is 1.18

200-day SMA

$2.09
LPTX price is currently -82.33% below its 200-day simple moving average

50-day SMA

$0.42
LPTX price is currently -11.43% below its 50-day simple moving average

RSI

46.64
LPTX 14-day relative strength index is 46.64

Volume

0.76
LPTX 30-day relative volume is 0.76

ATR

$0.05
LPTX average true range is $0.05

10-day Historical Volatility

163.24%
LPTX 10-day historical volatility is 163.24%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
LPTX annual revenue value is unknown

Revenue Analysts estimate

-
LPTX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
LPTX annual revenue 1-year change is unknown

Revenue Sector rank

-
LPTX annual revenue is unknown

EPS

EPS

-$1.81
LPTX annual earnings per share is -$1.81

EPS Analysts estimate

-$1.26
LPTX annual earnings per share is currently +43.65% higher than the consensus analysts' forecast

EPS 1-year change

+54.52%
LPTX annual earnings per share is up +54.52% year-on-year

EPS Sector rank

40.27%
LPTX annual earnings per share is higher than 40.27% of companies in Healthcare sector

Profit

Gross profit

-
LPTX annual gross profit value is unknown

Gross margin

-
LPTX annual gross profit margin value is unknown

Operating profit

-$70.06M
LPTX annual operating income is -$70.06 million

Operating margin

-
LPTX annual operating profit margin value is unknown

Net income

-$67.56M
LPTX annual net profit is -$67.56 million

Net margin

-
LPTX annual net profit margin value is unknown

Expenses

Total expenses

$70.06M
LPTX annual total expenses is $70.06 million

Operating expenses

$70.06M
LPTX annual total operating expenses is $70.06 million

Cost of goods sold

-
LPTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.85M
LPTX annual SGA is $12.85 million

Depreciation and amortization

$5000.00
LPTX annual depreciation & amortization is $5000.00

Interest expense

-
LPTX annual interest expense value is unknown

Income tax

$585.00K
LPTX annual income tax is $585.00 thousand

EBIT & EBITDA

EBIT

-$70.06M
LPTX annual earnings before interest & taxes is -$70.06 million

EBITDA

-$70.05M
LPTX annual EBITDA is -$70.05 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$49.12M
LPTX annual total assets is $49.12 million

Non current assets

$1.08M
LPTX annual long term assets is $1.08 million

Current assets

$48.04M
LPTX annual total current assets is $48.04 million

Cash and cash equivalents

$47.25M
LPTX annual cash & cash equivalents is $47.25 million

Accounts receivable

-
LPTX annual accounts receivable value is unknown

Inventory

-
LPTX annual inventory value is unknown

Liabilities

Total liabilities

$14.08M
LPTX annual total liabilities is $14.08 million

Long term liabilities

$0.00
LPTX annual total long term liabilities is $0.00

Current liabilities

$14.08M
LPTX annual total current liabilities is $14.08 million

Accounts payable

$4.74M
LPTX annual accounts payable is $4.74 million

Debt

Total debt

$266.00K
LPTX annual total debt is $266.00 thousand

Total debt 1-year change

+1.53%
LPTX annual total debt is up +1.53% year-on-year

Long term debt

-
LPTX annual long term debt value is unknown

Short term debt

$266.00K
LPTX annual short term debt is $266.00 thousand

Equity & Capital

Shareholders equity

$35.05M
LPTX annual stockholders equity is $35.05 million

Book value

$35.05M
LPTX annual book value is $35.05 million

Retained earnings

-$467.37M
LPTX annual retained earnings is -$467.37 million

Working capital

$33.96M
LPTX annual working capital is $33.96 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$60.30M
LPTX annual cash flow from operations is -$60.30 million

Cash from operations 1-year change

-37.82%
LPTX annual cash flow from operations is down -37.82% year-on-year

Cash from investing

$0.00
LPTX annual cash flow from investing activities is $0.00

Cash from investing 1-year change

-100%
LPTX annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$37.18M
LPTX annual cash flow from financing activities is $37.18 million

Cash from financing 1-year change

+124046.67%
LPTX annual cash flow from financing activities is up +124046.67% year-on-year

CAPEX

CAPEX

-
LPTX annual capital expenditures value is unknown

CAPEX 1-year change

-
LPTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$60.30M
LPTX annual free cash flow is -$60.30 million

Free cash flow 1-year change

-37.82%
LPTX annual free cash flow is down -37.82% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
LPTX annual gross profit margin value is unknown

Operating margin

-
LPTX annual operating profit margin value is unknown

Net margin

-
LPTX annual net profit margin value is unknown

ROA & ROE

ROA

-137.52%
LPTX annual return on assets is -137.52%

ROE

-192.75%
LPTX annual return on equity is -192.75%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LPTX price to earnings ratio value is unknown

PE ratio Sector rank

-
LPTX price to earnings ratio is unknown

PB Ratio

PB ratio

0.44
LPTX price to book ratio is 0.44

PB ratio Sector rank

27.98%
LPTX price to book ratio is higher than 27.98% of companies in Healthcare sector

PS Ratio

PS ratio

-
LPTX price to sales ratio value is unknown

PS ratio Sector rank

-
LPTX price to sales ratio is unknown

Enterprise value

Enterprise value

-$31.73M
LPTX enterprise value is -$31.73 million

Enterprise value Sector rank

2.73%
LPTX enterprise value is higher than 2.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.45
LPTX EV/EBITDA is 0.45

EV/EBITDA Sector rank

71.89%
LPTX EV/EBITDA is higher than 71.89% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.41
LPTX annual current ratio is 3.41

Quick ratio

-
LPTX annual quick ratio value is unknown

Leverage

Debt to equity

0.01
LPTX annual debt to equity ratio is 0.01

Interest coverage ratio

-
LPTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
LPTX piotroski f-score value is unknown

Altman Z-Score

-
LPTX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 27, 25 HC Wainwright & Co.
Neutral
Jan 16, 25 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
Jun 28, 24 Rodman & Renshaw
Buy
May 14, 24 HC Wainwright & Co.
Buy
Mar 19, 24 HC Wainwright & Co.
Buy
Mar 19, 24 Baird
Outperform
Nov 20, 23 Mizuho
Buy
Nov 14, 23 Raymond James
Outperform

Institutional Ownership

Similar stocks

CLDI logo
Calidi Biotherapeutics (CLDI)
IINN logo
Inspira Technologies Oxy BHN (IINN)
BFRG logo
Bullfrog AI Holdings (BFRG)
BIVI logo
BioVie (BIVI)
LFWD logo
ReWalk Robotics (LFWD)
CING logo
Cingulate (CING)
EDSA logo
Edesa Biotech (EDSA)
ONMD logo
OneMedNet (ONMD)
MIRA logo
MIRA Pharmaceuticals (MIRA)
  • What is the ticker symbol for Leap Therapeutics?
  • Does Leap Therapeutics pay dividends?
  • What sector is Leap Therapeutics in?
  • What industry is Leap Therapeutics in?
  • What country is Leap Therapeutics based in?
  • When did Leap Therapeutics go public?
  • Is Leap Therapeutics in the S&P 500?
  • Is Leap Therapeutics in the NASDAQ 100?
  • Is Leap Therapeutics in the Dow Jones?
  • When was Leap Therapeutics's last earnings report?
  • When does Leap Therapeutics report earnings?
  • Should I buy Leap Therapeutics stock now?

What is the ticker symbol for Leap Therapeutics?

The ticker symbol for Leap Therapeutics is NASDAQ:LPTX

Does Leap Therapeutics pay dividends?

No, Leap Therapeutics does not pay dividends

What sector is Leap Therapeutics in?

Leap Therapeutics is in the Healthcare sector

What industry is Leap Therapeutics in?

Leap Therapeutics is in the Biotechnology industry

What country is Leap Therapeutics based in?

Leap Therapeutics is headquartered in United States

When did Leap Therapeutics go public?

Leap Therapeutics's initial public offering (IPO) was on January 25, 2017

Is Leap Therapeutics in the S&P 500?

No, Leap Therapeutics is not included in the S&P 500 index

Is Leap Therapeutics in the NASDAQ 100?

No, Leap Therapeutics is not included in the NASDAQ 100 index

Is Leap Therapeutics in the Dow Jones?

No, Leap Therapeutics is not included in the Dow Jones index

When was Leap Therapeutics's last earnings report?

Leap Therapeutics's most recent earnings report was on Mar 26, 2025

When does Leap Therapeutics report earnings?

The next expected earnings date for Leap Therapeutics is May 13, 2025

Should I buy Leap Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page